HESI LPN
Nutrition Final Exam Quizlet
1. What is the primary intervention for a child experiencing a tonic-clonic seizure?
- A. Administer intravenous fluids
- B. Place the child in a prone position
- C. Protect the child from injury
- D. Perform mouth-to-mouth resuscitation
Correct answer: C
Rationale: The primary intervention for a child experiencing a tonic-clonic seizure is to protect them from injury. Placing the child in a prone position can be dangerous as it may lead to further harm due to the risk of aspiration or airway obstruction. Administering intravenous fluids is not recommended during a seizure. Performing mouth-to-mouth resuscitation is also not indicated as the child will resume breathing spontaneously after the seizure stops. Ensuring the child's safety and preventing injury by removing harmful objects and cushioning their head is essential until the seizure subsides.
2. What should be a priority for a 4-year-old child with nephrosis?
- A. Impaired body image
- B. Skin impairment
- C. Nutritional deficit
- D. Injury
Correct answer: B
Rationale: The correct answer is B: Skin impairment. Skin care is a priority in nephrosis due to edema and increased risk of skin breakdown, requiring careful monitoring and management. While impaired body image (Choice A) can be a concern, it is not typically a priority in a 4-year-old with nephrosis. Nutritional deficit (Choice C) is important but addressing skin impairment takes precedence due to the immediate risk of complications related to skin breakdown. Injury (Choice D) is a general concern for children but is not the priority in a child with nephrosis.
3. Before publication in a reputable journal, the findings of a research study must undergo scrutiny by experts in the field in a process known as what?
- A. peer review
- B. cohort review
- C. research intervention
- D. double-blind examination
Correct answer: A
Rationale: The correct answer is A: peer review. Before publication, research findings must undergo peer review, where experts in the field evaluate the validity and significance of the study. Choice B, cohort review, is incorrect as it does not involve the same level of evaluation by experts. Choice C, research intervention, is not a term used to describe the evaluation process before publication. Choice D, double-blind examination, refers to a study design where neither the participants nor the researchers know who is receiving a particular treatment, which is not the same as the peer review process.
4. What term describes foods that contain non-nutrient substances whose known action in the body is to promote well-being to a greater extent than that contributed by the food's nutrients?
- A. fortified foods
- B. enriched foods
- C. functional foods
- D. health-enhancing foods
Correct answer: C
Rationale: Functional foods are specifically designed to promote health benefits beyond basic nutrition. Fortified foods (choice A) are those with added nutrients that are not originally present, enriched foods (choice B) have nutrients added back that were lost during processing, and health-enhancing foods (choice D) is a vague and less specific term compared to functional foods.
5. What is the primary treatment for a child with acute otitis media?
- A. Antihistamines
- B. Nasal decongestants
- C. Antibiotics
- D. Ear drops
Correct answer: C
Rationale: The correct answer is C: Antibiotics. Antibiotics are the primary treatment for acute otitis media because the condition is often caused by a bacterial infection. Antihistamines (choice A) and nasal decongestants (choice B) are not the primary treatments for acute otitis media as they do not target the bacterial infection. Ear drops (choice D) are not the primary treatment for acute otitis media; antibiotics are required to treat the underlying bacterial cause.
Similar Questions
Access More Features
HESI LPN Basic
$69.99/ 30 days
- 50,000 Questions with answers
- All HESI courses Coverage
- 30 days access @ $69.99
HESI LPN Premium
$149.99/ 90 days
- 50,000 Questions with answers
- All HESI courses Coverage
- 30 days access @ $149.99